Global Cell-Free DNA (cfDNA) Testing Market Forecast to 2027
The global cell-free DNA (cfDNA) testing market is forecast to be worth USD 22.41 billion by 2027, according to a new report by Emergen Research. The global cell-free DNA (cfDNA) testing market is expected to grow significantly during the forecast period due to the increased incidence of cancer, the rising prevalence of chromosome abnormalities in babies due to an increasing number of late pregnancies, and the growing demand for non-invasive testing procedures. Besides, the increasing investments by governments to implement advanced therapeutic technology in hospitals are also expected to boost the market during the forecast period.
By carefully analyzing the vital commercial data and broad geographic dispersion of the business, Emergen Research created a market research study on Cell-Free DNA Testing. The study provides comprehensive coverage of the qualitative and quantitative analysis of the market for Cell-Free DNA Testing as well as important market statistics. The study paper offers current estimates through 2020 as well as historical data from 2017 to 2018. The profiles of both well-known and emerging industry participants in the research contain a summary of the company, its product portfolio, strategic relationships, and corporate expansion goals.
Cell-free DNA (cfDNA) testing, also known as non-invasive prenatal testing (NIPT), has revolutionized genetic testing by offering a safe and efficient alternative to invasive procedures. This cutting-edge technology analyzes the DNA fragments present in a person's blood, providing valuable insights into various genetic conditions and diseases. The cell-free DNA testing market has witnessed significant growth in recent years, driven by advancements in genomics, increasing awareness, and rising demand for non-invasive diagnostic methods.
Get Download Pdf Sample Copy of this Report @ https://www.emergenresearch.com/request-sample/156
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Cell-Free DNA (cfDNA) Testing market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
Key Companies Profiled in the Report are:
Sequenom, Inc., Quest Diagnostics, Illumina Inc., Agilent Technologies, Inc., Guardant Health, Inc., Biodesix, Inc., Allenex AB, Roche Holdings AG, Biocept, Inc., and CareDx, Inc., among others
Research Report on the Cell-Free DNA (cfDNA) Testing Market Addresses the Following Key Questions:
- Who are the dominant players of the Cell-Free DNA (cfDNA) Testing market?
- Which regional market is anticipated to have a high growth rate over the projected period?
- What consumer trends and demands are expected to influence the operations of the market players in the Cell-Free DNA (cfDNA) Testing market?
- What are the key growth drivers and restraining factors of the Cell-Free DNA (cfDNA) Testing market?
- What are the expansion plans and strategic investment plans undertaken by the players to gain a robust footing in the market?
- What is the overall impact of the COVID-19 pandemic on the Cell-Free DNA (cfDNA) Testing market and its key segments?
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/cell-free-dna-market
Some Key Highlights from the Report
- In August 2019, Agilent Technologies Inc. announced the acquisition of a leading manufacturer of innovative healthcare equipment, BioTek Instruments, Inc. This acquisition will expand Agilent’s product portfolio and its presence in North America.
- Cell-free fetal DNA is a non-invasive procedure and therefore does not pose a health risk of CVS (chorionic villus sampling) or amniocentesis, like pain and any slight chance of infection. Due to these benefits, the cell-free fetal DNA segment held the largest market share of 48.8% in the Cell-Free DNA (cfDNA) testing market, in 2019.
- The MPSS technology segment is anticipated to dominate the global market with a CAGR of 26.7%, owing to the advantage of producing a measurable profile of gene expression in cells or tissues.
- The gynecology segment is anticipated to lead the market during the forecasted period, as the cell-free DNA approach is being used to detect genetic issues of baby and to diagnose pregnancy complications such as pregnancy loss.
- North America is accounted for the largest market with a share of 33.6% in 2019, owing to the increasing chronic diseases and pregnancy problems in this region due to the changes in lifestyles of the population. Besides, the adoption of advanced technology in hospitals is also expected to boost the market shortly.
Market Segmentations of the Cell-Free DNA (cfDNA) Testing Market
This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2020 and 2027. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Cell-Free DNA (cfDNA) Testing market on the basis of product, application, and region:
Segments Covered in this report are:
- Type Outlook (Revenue, USD Billion; 2017-2027)
- Cell-free fetal DNA (NIPT)
- Circulating tumor DNA
- Donor-derived cell-free DNA
- Technology Outlook (Revenue, USD Billion; 2017-2027)
- MPSS
- t-MPS
- SNP
- Others
- Application Outlook (Revenue, USD Billion; 2017-2027)
- Transplantation
- Gynecology
- Oncology
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/156
Regional Landscape section of the Cell-Free DNA (cfDNA) Testing report offers deeper insights into the regulatory framework, current and emerging market trends, production and consumption patterns, supply and demand dynamics, import/export, and presence of major players in each region.
The various regions analyzed in the report include:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key reasons to buy the Global Cell-Free DNA (cfDNA) Testing Market report:
- The latest report comprehensively studies the global Cell-Free DNA (cfDNA) Testing market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.
- The report offers an insightful analysis of the regional outlook of the market.
- It offers a detailed account of the end-use applications of the products services offered by this industry.
- The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.
In conclusion, the Cell-Free DNA (cfDNA) Testing Market report is an exhaustive database that will help readers formulate lucrative strategies. The Cell-Free DNA (cfDNA) Testing Market report studies the latest economic scenario with value, drivers, constraints, growth opportunities, challenges, demand and supply ratio, production capacity, import/export status, growth rate, and others. Additionally, the report also undertakes SWOT Analysis and Porter’s Five Forces Analysis to study the leading companies.
Request Customization as per your specific requirement @ https://www.emergenresearch.com/request-for-customization/156
Thank you for reading our report. To know more about the customization feature, please get in touch with us, and our team will ensure the report is customized to meet your requirements.
Latest Reports by Emergen Research:
Action Camera Market
Medical Electronics Market
Aerospace 3D Printing Market
https://prtimes.jp/main/html/rd/p/000000122.000082259.html
Carbon Footprint Management Market
Electronic Warfare Market
Speaker Driver Market
construction equipment rental market
https://prtimes.jp/main/html/rd/p/000000161.000082259.html
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Latest Report: Veterinary Care Market, Veterinary Dental Equipment Market
Trending Title: CRISPER/Cas9 Technology Devices Market, Fecal Transplant Therapy Market
